Felty's syndrome, unspecified site
ICD-10 M05.00 is a billable code used to indicate a diagnosis of felty's syndrome, unspecified site.
Felty's syndrome is a rare autoimmune disorder characterized by the triad of rheumatoid arthritis (RA), splenomegaly, and neutropenia. It primarily affects individuals with long-standing RA, leading to systemic complications. Anatomically, the condition involves the joints, particularly the hands and feet, where inflammation can cause pain, swelling, and deformities. The spleen, an organ involved in immune response, becomes enlarged due to the increased demand for blood cell production. Clinically, patients may present with joint stiffness, fatigue, and recurrent infections due to low white blood cell counts. The pathophysiology involves immune dysregulation, where the body mistakenly attacks its own tissues, leading to chronic inflammation and joint damage. Diagnosis is often confirmed through clinical evaluation, laboratory tests for rheumatoid factor, anti-CCP antibodies, and imaging studies to assess joint involvement.
Orthopedic documentation should include detailed imaging reports (X-rays, MRIs) showing joint damage, functional assessments, and treatment plans addressing joint preservation.
Patients may require surgical intervention for joint deformities or severe pain management, necessitating clear documentation of the orthopedic approach.
Joint-specific considerations include the degree of deformity, range of motion limitations, and the impact on daily activities.
Rheumatologic documentation must include lab results indicating inflammation markers (ESR, CRP), disease activity scores, and assessments of systemic involvement.
Management of Felty's syndrome often involves immunosuppressive therapies and monitoring for complications related to neutropenia.
Systemic involvement may necessitate interdisciplinary collaboration, particularly in managing infections due to neutropenia.
Functional assessments should evaluate mobility limitations, pain levels, and the need for assistive devices to enhance patient independence.
Rehabilitation may focus on improving joint function and overall physical conditioning to counteract the effects of RA and Felty's syndrome.
Mobility limitations may require tailored rehabilitation programs to address specific joint impairments and enhance quality of life.
Used for follow-up visits to manage Felty's syndrome and monitor treatment efficacy.
Documentation must include history, examination findings, and treatment plan.
Rheumatology and primary care considerations for ongoing management.
Used when joint effusion is present in patients with Felty's syndrome.
Indicate the joint involved and the reason for the procedure.
Orthopedic considerations for joint management.
Common symptoms include joint pain and swelling, recurrent infections due to neutropenia, fatigue, and splenomegaly. Patients may also experience systemic symptoms related to rheumatoid arthritis.
